Mirum develops and sells medicines for rare liver and other rare diseases, based in Foster City, California. It last closed at $96.13 on Nov 20, up 0.65% on the day. The next earnings report for MIRM is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, MIRM reported EPS of -$0.87 on revenue of $185.7M, with revenue up 39.6% from a year ago. Over its last 8 reports the stock moved an average of 8.8% the session after earnings. Over the last 12 months MIRM insiders bought $9.0M of stock on the open market and sold $45.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is MIRM in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MIRM.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MIRMStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MIRM · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend, nearing overbought
The stock is 5% above its 20 day and 8% above its 50 day average. It is 2% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 63), near overbought. The nearest support is the swing low (Aug 25) at $95.00, and the nearest resistance the Pivot at $96.21.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityNormal, 4.0%/day
Key levels
$130.0052 week high+35.2%
$98.97Swing high (Nov 5)+3.0%
$98.31Pivot R1+2.3%
$98.17200 day average+2.1%
$97.75100 day average+1.7%
$96.21Pivot+0.1%
$96.13Last close
$95.00Swing low (Aug 25)−1.2%
$94.02Pivot S1−2.2%
$91.0120 day average−5.3%
$88.1950 day average−8.3%
$63.2352 week low−34.2%
Indicators
RSI (14)
62.53
Strong, overbought above 70
Neutral
MACD
2.09
Above its signal line
Bullish
Stochastic
73.1
Middle of its range
Neutral
ADX (14)
24.8
Weak trend
Williams %R
-17.9
Oversold below −80, overbought above −20
Overbought
CCI (20)
99.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.6%
Change over 10 sessions
Bullish
ATR (14)
$3.80
Typical daily range, 4.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 9.5%/day
Key levels
$130.0052 week high+35.2%
$98.97Swing high (Nov 5)+3.0%
$98.31Pivot R1+2.3%
$98.17200 day average+2.1%
$97.75100 day average+1.7%
$96.21Pivot+0.1%
$96.13Last close
$95.00Swing low (Aug 25)−1.2%
$94.02Pivot S1−2.2%
$91.0120 day average−5.3%
$88.1950 day average−8.3%
$63.2352 week low−34.2%
Indicators
RSI (14)
51.73
Middle of its range
Neutral
MACD
-2.35
Below its signal line
Bearish
Stochastic
61.0
Middle of its range
Neutral
ADX (14)
18.1
No clear trend
Williams %R
-31.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-19.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−2.1%
Change over 10 sessions
Bearish
ATR (14)
$9.09
Typical daily range, 9.5% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for MIRM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MIRM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow MIRM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MIRMHow many large options trades hit MIRM, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MIRM in the last 90 days.
From SEC Form 4 filings by MIRM's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MIRM is in one of them and how their past MIRM trades turned out.
Mirum Pharmaceuticals is a biopharmaceutical company based in Foster City, California, that develops and sells medicines for rare diseases, mainly rare liver conditions. Its approved products are Livmarli, used to treat severe itching in certain rare cholestatic liver diseases, and Cholbam and Ctexli, used for bile acid disorders and a rare brain and tendon condition. It sells these medicines mainly in the United States and through partners in other countries, and it is developing treatments for other rare liver diseases and a rare genetic neurological disorder. Its customers include patients, physicians and specialty pharmacies.